Drug Shortage Report for APO-TADALAFIL

Last updated on 2022-04-29 History
Report ID 157332
Drug Identification Number 02422107
Brand name APO-TADALAFIL
Common or Proper name TADALAFIL
Company Name APOTEX INC
Market Status MARKETED
Active Ingredient(s) TADALAFIL
Strength(s) 10MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 4 BLS
ATC code G04BE
ATC description OTHER UROLOGICALS, INCL ANTISPASMODICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-03-22
Estimated end date 2022-04-29
Actual end date 2022-04-28
Shortage status Resolved
Updated date 2022-04-29
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2022-04-29 French Compare
v5 2022-04-29 English Compare
v4 2022-04-21 French Compare
v3 2022-04-21 English Compare
v2 2022-03-25 French Compare
v1 2022-03-25 English Compare

Showing 1 to 6 of 6